Other OTC - Delayed Quote • USD
Lotus Pharmaceuticals, Inc. (LTUS)
As of 11:13 AM EDT. Market Open.
Breakdown
TTM
Total Revenue
71,391.0020
Cost of Revenue
45,943.5230
Gross Profit
25,447.4790
Operating Expense
17,281.9160
Operating Income
8,165.5630
Net Non Operating Interest Income Expense
-245.7200
Other Income Expense
-6,433.8830
Pretax Income
1,485.9600
Tax Provision
-250.0730
Net Income Common Stockholders
1,736.0330
Diluted NI Available to Com Stockholders
1,736.0330
Basic EPS
-0.23
Diluted EPS
-0.23
Basic Average Shares
53,611.6590
Diluted Average Shares
54,827.4020
Total Operating Income as Reported
1,402.9040
Total Expenses
63,225.4390
Net Income from Continuing & Discontinued Operation
1,736.0330
Normalized Income
5,918.0570
Interest Income
2.4360
Interest Expense
248.1560
Net Interest Income
-245.7200
EBIT
1,734.1160
EBITDA
3,873.6010
Reconciled Cost of Revenue
45,943.5230
Reconciled Depreciation
2,139.4850
Net Income from Continuing Operation Net Minority Interest
1,736.0330
Total Unusual Items Excluding Goodwill
-6,433.8830
Total Unusual Items
-6,433.8830
Normalized EBITDA
10,307.4840
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
-2,251.8591
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade